Clinical Trials on Neurofibromas
Total 283 results
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Neoplasm of Uncertain Malignant PotentialUnited States
-
Children's National Research InstituteActive, not recruitingNeurofibromatosis 1 | Neurofibroma | Plexiform Neurofibroma | Atypical Neurofibroma | Atypical Neurofibromatosis | Von Recklinghausen DiseaseUnited States
-
National Cancer Institute (NCI)TerminatedNeurofibromatosis Type 1 | Plexiform Neurofibroma | Spinal Cord NeurofibromaUnited States
-
University of PittsburghNational Cancer Institute (NCI)Completed
-
Shanghai Fosun Pharmaceutical Industrial Development...RecruitingNeurofibromatosis 1 | NF1 | Plexiform NeurofibromaChina
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingNeurofibromatosis 1 | Plexiform Neurofibroma (PN)United States, Canada, France, Italy, Germany, China, United Kingdom, Spain, Japan, Russian Federation, Australia, Poland, Brazil
-
Shanghai Ninth People's Hospital Affiliated to...RecruitingNeurofibromatosis 1 | Plexiform NeurofibromaChina
-
University of Alabama at BirminghamChildren's Hospital of Philadelphia; Congressionally Directed Medical Research...Not yet recruitingNeurofibromatosis 1 | Plexiform Neurofibroma
-
Spectrum Health HospitalsVan Andel Research InstituteRecruitingNeurofibromatosis Type 1 | Plexiform Neurofibromas | Cutaneous NeurofibromasUnited States
-
National Cancer Institute (NCI)CompletedPlexiform Neurofibroma | Neurofibromatosis Type IUnited States
-
National Cancer Institute (NCI)Active, not recruitingNeurofibromatosis 1 (NF1) | Plexiform Neurofibromas (PN)United States
-
AstraZenecaMerck Sharp & Dohme LLCCompletedNeurofibromatosis 1 | Neurofibroma PlexiformChina
-
University of Alabama at BirminghamPacific Pediatric Neuro-Oncology Consortium; Array BioPharmaActive, not recruitingNeurofibromatosis Type 1 | Plexiform NeurofibromaUnited States
-
Assistance Publique - Hôpitaux de ParisNovartisCompletedNeurofibromatoses | Neurofibromatosis Type 1 | Plexiform NeurofibromaFrance
-
Novartis PharmaceuticalsTerminatedPlexiform Neurofibroma Associated With Neurofibromatosis Type 1Israel
-
AstraZenecaApproved for marketingNF type1 With Inoperable Plexiform NeurofibromasUnited States
-
SpringWorks Therapeutics, Inc.Active, not recruitingPlexiform Neurofibroma | Neurofibromatosis Type 1 (NF1)United States
-
SpringWorks Therapeutics, Inc.AvailableNeurofibromatosis Type 1-Associated Plexiform Neurofibromas | Histiocytic Neoplasm | Other MAP-K Pathway Driven Diseases
-
Kent RobertsonCompletedNeurofibromatosis | NeurofibromasUnited States
-
Children's Hospital of PhiladelphiaUnited States Department of DefenseTerminated
-
AstraZenecaCompletedHealthy Participants | Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs)United States
-
St. Justine's HospitalTerminatedPlexiform NeurofibromasCanada
-
Shanghai Kechow Pharma, Inc.RecruitingNeurofibromatosis 1 | Plexiform NeurofibromasChina
-
National Cancer Institute (NCI)RecruitingNeurofibromatosis 1 | Plexiform NeurofibromasUnited States
-
National Cancer Institute (NCI)Completed
-
St. Justine's HospitalCHU de Quebec-Universite Laval; Montreal Children's Hospital of the MUHCActive, not recruitingLow-grade Glioma | Plexiform Neurofibroma | Central Nervous System GliomaCanada
-
AlexionRecruiting
-
Indiana UniversityNovartisCompletedNeurofibromatosis | NF1 | NeurofibromasUnited States
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Plexiform NeurofibromasUnited States
-
University of Alabama at BirminghamCompletedNeurofibromatosis | Plexiform Neurofibromas | NF1United States
-
National Cancer Institute (NCI)CompletedPlexiform Neurofibromas | NF1United States
-
Indiana UniversityPfizer; United States Department of DefenseTerminatedNeurofibromatosis | Plexiform Neurofibromas | NF1United States
-
Novartis PharmaceuticalsCompletedCancerFrance, Australia, United States, Canada, United Kingdom
-
Children's Hospital of PhiladelphiaCompletedNeurofibromatosis Type 1 | Precancerous ConditionUnited States
-
Children's Hospital of PhiladelphiaTerminatedNeurofibromatosis Type 1 | Precancerous ConditionUnited States
-
Shanghai Fosun Pharmaceutical Industrial Development...Active, not recruitingNeurofibromatosis 1 | NF1 | Plexiform NeurofibromaUnited States, China, Spain
-
Great Ormond Street Hospital for Children NHS Foundation...AstraZenecaCompletedNeurofibromatosis Type 1 | Optic Nerve Glioma | Plexiform NeurofibromaUnited Kingdom
-
Medical University of ViennaUnknownCutaneous NeurofibromasAustria
-
Massachusetts General HospitalJohns Hopkins UniversityNot yet recruitingNeurofibromatosis 1 | Neurofibromas, CutaneousUnited States
-
AstraZenecaRecruitingNeurofibroma, PlexiformChina
-
Nicholas GulatiActive, not recruiting
-
Johns Hopkins UniversityNeurofibromatosis Therapeutic Acceleration ProgramRecruitingCutaneous Neurofibroma | NF1 | MonotherapyUnited States
-
Region SkaneNovartisActive, not recruitingChild | Neurofibromatosis 1 | Neurofibroma, PlexiformSweden
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedNeurofibromatosis 1 | Neurofibroma, PlexiformUnited States
-
Massachusetts General HospitalCompletedNeurofibromatosis Type 1 | Cutaneous NeurofibromasUnited States
-
AstraZenecaNot yet recruitingNeurofibromatosis 1 | Neurofibroma, Plexiform
-
NFlection Therapeutics, Inc.CompletedNeurofibromatosis 1 | Cutaneous NeurofibromaUnited States
-
Joergen SerupSahlgrenska University Hospital, SwedenActive, not recruitingCutaneous NeurofibromaDenmark, Sweden
-
NFlection Therapeutics, Inc.CompletedNeurofibromatosis 1 | Cutaneous NeurofibromaUnited States